시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 듀얼 챔버형 페이스메이커 시장 보고서(2025년)
Dual Chamber Pacemaker Global Market Report 2025
상품코드 : 1764304
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,650,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,612,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,575,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

듀얼 챔버형 페이스메이커 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 심장 건강에 대한 의식 증가, 헬스케어 지출 증가에 기인하고 있습니다. 이 기간에 예상되는 주요 동향에는 무연 페이스메이커의 기술적 진보, 원격 모니터링 기술의 도입, 배터리 기술의 개선, Bluetooth와 무선 텔레메트리의 통합, 디바이스 소형화의 혁신 등이 있습니다.

심혈관 질환의 유병률의 상승은 향후 몇 년간의 듀얼 챔버형 페이스메이커 시장의 성장을 가속할 것으로 예측됩니다. 주로 비만과 관련 심장 합병증의 원인이 되는 앉아있는 라이프 스타일과 식생활의 혼란에 기인하고 있습니다. 예를 들면, 2024년 10월, 미국을 거점으로 하는 정부기관인 질병 대책 예방 센터는 2022년에는 심장병이 70만 2,880명의 사망의 원인이 되어, 사망 망자의 5명에 1명을 차지한다고 보고했습니다. 또한 미국에서는 연간 약 80만 5,000명이 심장 발작에 시달리고 있습니다.

듀얼 챔버형 페이스메이커 시장의 주요 기업은 환자의 쾌적성을 향상시키고 감염 위험을 최소화하고 장치의 수명을 연장하기 위해 듀얼 챔버형 리드 레스페이스메이커와 같은 선진 제품의 개발에 주력하고 있습니다. 심장의 심방과 심실을 조절하는 컴팩트한 이식형 장치로 합병증을 줄이고 심장의 리듬 관리를 강화합니다. 예를 들어, 2023년 7월, 미국에 본사를 둔 의료 기기 제조업체인 Abbott Laboratories는 미국 식품의약국으로부터 승인을 받은 듀얼 챔버 리드리스 심박 조율기인 AVEIR를 출시했습니다. 이 혁신적인 시스템은 우심방과 우심실에 장착하는 2개의 소형 디바이스로 구성되어, 무선으로 통신하는 것으로, 심장의 리듬에 이상이 있는 환자나 느린 환자에 동기한 페이싱을 실시해 모두의 일반적인 페이스메이커의 적응증에 대응합니다. 리드리스 설계에 의해 와이어나 수술용 포켓이 불필요하게 되어, 합병증이 감소해, 환자의 쾌적성이 향상합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

KTH
영문 목차

영문목차

A dual-chamber pacemaker is a medical device implanted in the chest to manage irregular heart rhythms by regulating the activity of the right atrium and right ventricle. It features two leads, each positioned in one of these heart chambers, enabling it to detect the heart's electrical signals and deliver electrical impulses when needed. This device helps maintain a normal, synchronized heartbeat by coordinating the timing of atrial and ventricular contractions.

The main types of pacemakers include single-chamber pacemakers, dual-chamber pacemakers, and biventricular pacemakers. Single-chamber pacemakers pace only one heart chamber, either the atrium or the ventricle. Various technologies are employed, such as Micra pacemakers, conventional pacemakers, leadless pacemakers, and remote monitoring systems. These devices are distributed through multiple channels, including direct sales, distributors, and online platforms. They are used to treat conditions like atrial fibrillation, bradycardia, heart block, and cardiac resynchronization therapy. The primary end-users include hospitals, cardiac care centers, ambulatory surgical centers, and home healthcare providers.

The dual chamber pacemaker market research report is one of a series of new reports from The Business Research Company that provides dual chamber pacemaker market statistics, including the dual chamber pacemaker industry's global market size, regional shares, competitors with the dual chamber pacemaker market share, detailed dual chamber pacemaker market segments, market trends and opportunities, and any further data you may need to thrive in the dual chamber pacemaker market. This dual-chamber pacemaker market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The dual-chamber pacemaker market size has grown strongly in recent years. It will grow from $3.98 billion in 2024 to $4.24 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth during the historic period can be attributed to an increasing preference for home-based cardiac monitoring, a rise in cardiac surgeries and device implantations, growing demand for personalized cardiac care, a higher incidence of lifestyle-related disorders, and an expanding number of specialized cardiac care centers.

The dual-chamber pacemaker market size is expected to see strong growth in the next few years. It will grow to $5.44 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%.The projected growth during the forecast period can be attributed to the increasing prevalence of cardiovascular diseases, an expanding aging population, greater adoption of minimally invasive cardiac procedures, heightened awareness of cardiac health, and rising healthcare expenditure. Key trends expected in this period include technological advancements in leadless pacemakers, the incorporation of remote monitoring technologies, improvements in battery technology, integration of Bluetooth and wireless telemetry, and innovations in device miniaturization.

The rising prevalence of cardiovascular diseases is expected to drive the growth of the dual-chamber pacemaker market in the coming years. Cardiovascular diseases are conditions that impact the heart and blood vessels, causing issues such as heart attacks and strokes. This increase is primarily attributed to sedentary lifestyles and poor dietary habits, which contribute to obesity and related heart complications. Dual-chamber pacemakers assist in treating cardiovascular diseases by regulating the heart's rhythm through electrical impulses delivered to the atrium and ventricle, enhancing coordination and promoting efficient blood circulation. For example, in October 2024, the Centers for Disease Control and Prevention, a U.S.-based government agency, reported that in 2022, heart disease was responsible for 702,880 deaths, accounting for one in every five deaths. Additionally, approximately 805,000 people in the United States suffer a heart attack annually. Thus, the growing prevalence of cardiovascular diseases is fueling the expansion of the dual-chamber pacemaker market.

Leading companies in the dual-chamber pacemaker market are focusing on developing advanced products like the dual-chamber leadless pacemaker to improve patient comfort, minimize infection risks, and extend device longevity. A dual-chamber leadless pacemaker is a compact, implantable device that regulates the heart's atrium and ventricle without the use of traditional leads, thereby reducing complications and enhancing cardiac rhythm management. For example, in July 2023, Abbott Laboratories, a U.S.-based medical device manufacturer, launched AVEIR, a dual-chamber leadless pacemaker that received approval from the U.S. Food and Drug Administration. This innovative system comprises two miniaturized devices-one placed in the right atrium and the other in the right ventricle-that communicate wirelessly to deliver synchronized pacing for patients with abnormal or slow heart rhythms, addressing all common pacemaker indications. The leadless design eliminates the need for wires and surgical pockets, reducing complications and boosting patient comfort. Clinical trials showed high safety and efficacy, with a 98% implant success rate and over 97% atrioventricular synchrony.

In July 2022, Orchestra BioMed Holding, a U.S.-based biomedical innovation company, formed a partnership with Medtronic Plc to advance innovation in hypertension treatment. The collaboration focuses on developing and commercializing the BackBeat Cardiac Neuromodulation Therapy specifically for hypertension in patients with pacemakers. Medtronic Plc, based in Ireland, is a medical device company known for manufacturing advanced dual-chamber pacemakers.

Major players in the dual chamber pacemaker market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, UC Health, Biotronik SE & Co. KG, Integer Holdings Corporation, LivaNova PLC, Lepu Medical Technology(Beijing)Co.,Ltd., MicroPort Scientific Corporation, Oscor Inc., Sorin Group, BPL Medical Technologies, EBR Systems Inc., Narang Medical Limited, Vitatron, Medico S.p.A., Osypka Medical GmbH, Shree Pacetronix Ltd., Medinnova Systems Pvt. Ltd, Skrip Electronics.

North America was the largest region in the dual chamber pacemaker market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in dual chamber pacemaker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the dual chamber pacemaker market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dual chamber pacemaker market also consist of sales of implantable devices, accessories and components, and external temporary pacemakers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dual Chamber Pacemaker Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dual chamber pacemaker market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for dual chamber pacemaker ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dual chamber pacemaker market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Dual Chamber Pacemaker Market Characteristics

3. Dual Chamber Pacemaker Market Trends And Strategies

4. Dual Chamber Pacemaker Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Dual Chamber Pacemaker Growth Analysis And Strategic Analysis Framework

6. Dual Chamber Pacemaker Market Segmentation

7. Dual Chamber Pacemaker Market Regional And Country Analysis

8. Asia-Pacific Dual Chamber Pacemaker Market

9. China Dual Chamber Pacemaker Market

10. India Dual Chamber Pacemaker Market

11. Japan Dual Chamber Pacemaker Market

12. Australia Dual Chamber Pacemaker Market

13. Indonesia Dual Chamber Pacemaker Market

14. South Korea Dual Chamber Pacemaker Market

15. Western Europe Dual Chamber Pacemaker Market

16. UK Dual Chamber Pacemaker Market

17. Germany Dual Chamber Pacemaker Market

18. France Dual Chamber Pacemaker Market

19. Italy Dual Chamber Pacemaker Market

20. Spain Dual Chamber Pacemaker Market

21. Eastern Europe Dual Chamber Pacemaker Market

22. Russia Dual Chamber Pacemaker Market

23. North America Dual Chamber Pacemaker Market

24. USA Dual Chamber Pacemaker Market

25. Canada Dual Chamber Pacemaker Market

26. South America Dual Chamber Pacemaker Market

27. Brazil Dual Chamber Pacemaker Market

28. Middle East Dual Chamber Pacemaker Market

29. Africa Dual Chamber Pacemaker Market

30. Dual Chamber Pacemaker Market Competitive Landscape And Company Profiles

31. Dual Chamber Pacemaker Market Other Major And Innovative Companies

32. Global Dual Chamber Pacemaker Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dual Chamber Pacemaker Market

34. Recent Developments In The Dual Chamber Pacemaker Market

35. Dual Chamber Pacemaker Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기